Loading chat...
MN HF2672
Bill
Status
3/8/2016
Primary Sponsor
Barb Yarusso
Click for details
AI Summary
-
Amends Minnesota Statutes section 256B.0625 to expand coverage of gender dysphoria treatment under medical assistance, changing the focus from sex reassignment surgery to broader treatment of gender dysphoria.
-
Requires sex reassignment surgery coverage only when medically necessary, replacing previous language that prohibited such coverage.
-
Allows the commissioner to include drugs for gender dysphoria treatment in the drug formulary if the drug is FDA-approved for marketing.
-
Requires prescribed drugs meet clinical guidelines or practice parameters from the National Guideline Clearinghouse maintained by the Agency for Healthcare Research and Quality (AHRQ).
-
Limits formulary inclusion to drugs where no other drug or treatment regimen is already available within the formulary to treat the condition.
Legislative Description
Medically necessary gender dysphoria and prescribed drugs for treatment of gender dysphoria medical assistance coverage required.
Last Action
Authors added Ward, Lillie, and Clark.
5/5/2016